{"id":"W4283325455","doi":"10.1097/01.hs9.0000843736.56298.a7","title":"S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (ZUMA-7)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hazard ratio; Internal medicine; Oncology; Refractory (planetary science); Phases of clinical research; Surgery; Clinical trial; Lymphoma; Confidence interval; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004335528,0.001311516,0.001909533,0.0004068724,0.000469974,0.001292275,0.0009079774,0.001433121,0.004637602],"category_scores_gemma":[0.001995937,0.0004355556,0.004557779,0.0005244738,0.0008769279,0.0008383768,0.000659411,0.002740198,0.0008612079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001087565,"about_ca_system_score_gemma":0.001505928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008502436,"about_ca_topic_score_gemma":0.002550996,"domain_scores_codex":[0.9986116,0.0008369926,0.00007927175,0.0001489931,0.0001287396,0.0001944116],"domain_scores_gemma":[0.9981603,0.0003993869,0.0004862564,0.0001813759,0.0001478881,0.0006246818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9449495,0.01697767,0.01059781,0.0004896653,0.003670232,0.00006964085,0.00008519671,0.000675293,0.003400285,0.0000853623,0.001539778,0.01745963],"study_design_scores_gemma":[0.629186,0.3195364,0.04291803,0.0000638088,0.00360611,0.0001943511,0.0001025237,0.001010217,0.001480128,0.0002084687,0.001640998,0.00005307359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939546,0.002021586,0.0001347456,0.0002961389,0.00009907216,0.0007367177,0.001866139,0.00002467635,0.0008662643],"genre_scores_gemma":[0.989472,0.00103775,0.0006247991,0.001001821,0.0002738371,0.001575946,0.004884773,0.00001848639,0.001110492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004637602,"threshold_uncertainty_score":0.02292871,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02406320880621695,"score_gpt":0.3345384065848873,"score_spread":0.3104751977786704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}